Resistance to the BH3 peptidomimetic obatoclax in non-small cell lung cancer associated with a block in BCL-2 family post-translational regulation

Francis McCoy, Jane Hurwitz, Alex D Chacko, Ian Paul, Fabio Liberante, Barry O'Hagan, George McKerr, Patrick Johnston, Dean A Fennell

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)S592
JournalJournal of Thoracic Oncology
Volume4
Issue number9, Sup
Publication statusPublished - Sep 2009

Cite this

McCoy, F., Hurwitz, J., Chacko, A. D., Paul, I., Liberante, F., O'Hagan, B., McKerr, G., Johnston, P., & Fennell, D. A. (2009). Resistance to the BH3 peptidomimetic obatoclax in non-small cell lung cancer associated with a block in BCL-2 family post-translational regulation. Journal of Thoracic Oncology, 4(9, Sup), S592.